NICE gives EYLEA a provisional green light to treat patients with visual impairment due to diabetic macular oedema
Bayer HealthCare is pleased that NICE has recognised the benefits of EYLEA (aflibercept solution for injection) for the treatment of visual impairment due to diabetic macular oedema (DMO) according...